Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia Research Letter

   

Authors:	Bewersdorf, J. P.; Patel, K. K.; Goshua, G.; Shallis, R. M.; Podoltsev, N. A.; Huntington, S. F.; Zeidan, A. M.
Title:	Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
Journal Title:	Blood
Volume:	139
Issue:	11
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2022-03-17
Start Page:	1766
End Page:	1770
Language:	English
DOI:	10.1182/blood.2021014401
PUBMED:	35298594
PROVIDER:	scopus
PMCID:	PMC8931513
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126368024&doi=10.1182%2fblood.2021014401&partnerID=40&md5=69fde29e980cc8fb03fd0ad8061a6e1c
Notes:	Letter -- Export Date: 1 April 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/193344